The U.S. atherosclerosis treatment market is driven by a high prevalence of cardiovascular diseases, pharmaceutical advancements, an aging population, lifestyle risks, and government health ...

Here, we aim to investigate macrophages-related genes in the deterioration of atherosclerosis. Methods ... to all the peer reviewers for their opinions and suggestions. CAD, Coronary artery disease; ...

Coronary atherosclerotic heart disease ... stabilize vulnerable plaque and delay the progression of atherosclerosis by inhibiting inflammation, regulating the polarization of macrophages and promoting ...

Atherosclerosis and its related laboratory biomarkers. Int J Mol Sci. 2023. Vol. 24(21):15546 Quero L, Tiaden AN, Hanser E, Roux J, Laski A, Hall J, et al.. miR-221-3p drives the shift of ...

In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...

CD8+ T cells accumulate in atherosclerotic plaques. Researchers identify a crucial signaling pathway -- with therapeutic potential.

One type of immune cell residing in nerves, a pro-inflammatory macrophage, began producing chemokines. These signaling molecules recruited a second population of circulating macrophages ...

CD8+ T cells accumulate in atherosclerotic plaques. LMU researchers identify a crucial signaling pathway—with therapeutic potential.

The researchers hypothesized that due to the high prevalence of atherosclerosis in this population, patients entering lung cancer treatment may benefit from coronary calcium scoring. Data were ...

For select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to ...